A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in Northeast Brazil

A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in a Socioeconomically Disadvantaged Population and Professionals Working in a City Located in Northeast Brazil

The objective of this study is to investigate vaccination acceptance and identify the reasons why people are not vaccinated.

People over 18 years of age who live in neighborhoods with socioeconomic vulnerability and with many cases of infectious diseases, as well as health professionals, will respond to a research questionnaire.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

2500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Vulnerable populations residing in neighborhoods characterized by socioeconomic vulnerability and high infectious disease incidence. Four neighborhoods in Natal will be the focus, each with their respective population: Lagoa Azul (61,289), Pajuçara (58,021), Felipe Camarão (50,997), and Planalto (31,206).

In this project, the inclusion of health professionals as a unified group is essential because of their critical role as trusted source of health information. In Natal, these professionals consist of 5,238 physicians and an estimated 7,066 nurses (derived from a 61.6% prevalence applied to the 11,471 registered nurses in Rio Grande do Norte).

Description

Inclusion Criteria:

  • Individuals who are over 18 years old and are residents of the PAJUÇARA, FELIPE CAMARÃO, LAGOA AZUL, or PLANALTO neighborhoods, willing to answer the study questionnaire.
  • Healthcare professionals who work in Natal, willing to answer the study questionnaire.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Vulnerable group
Individuals who are over 18 years old and are residents of the socioeconomically vulnerable neighborhoods.
A survey questionnaire to assess factors related to vaccination adherence, including factors such as vaccine novelty, cost, and prior knowledge among vulnerable populations.
Health Professionals
Healthcare professionals who work in Natal.
A survey questionnaire to assess factors related to vaccination adherence, including factors such as vaccine novelty, cost, and prior knowledge among vulnerable populations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resistance to adherence to vaccination
Time Frame: Baseline
Resistance to adherence to vaccination will be measured using a questionnaire developed for this survey. The questionnaire will be described by mean and standard deviation, and the distribution frequency of each item will be presented, comparing cohorts of health professionals and populations in socioeconomic vulnerability.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Kleber G Luz, PhD, Centro de Estudos e Pesquisas em Moléstias Infecciosas

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2024

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

August 19, 2024

First Submitted That Met QC Criteria

November 4, 2024

First Posted (Estimated)

November 5, 2024

Study Record Updates

Last Update Posted (Estimated)

November 5, 2024

Last Update Submitted That Met QC Criteria

November 4, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • EII1001HEVANO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe